Transplacental passage of maternal erythrocytes with sickling.

The Journal of Pediatrics
T Fujikura, B Klionsky

Abstract

Sickled erythrocytes served as a marker for maternal blood in a cell transfer study of placentas from uncomplicated term pregnancies of women with sicklemia. The incidence of concurrent sickling in maternal and fetal blood was 100% in the 44 cases examined. Maternofetal passage of the erythrocytes was found four times more frequently in umbilical or chorionic veins (8.4%) than in arteries (1.9%). Deported chorionic villi were found in the veins in three of 44 cases but not in the arteries. These findings indicate fresh maternofetal leakage of blood during the third stage of labor.

References

Mar 9, 1967·The New England Journal of Medicine·J F Taylor
Jun 1, 1955·Proceedings of the Society for Experimental Biology and Medicine·R G SCHNEIDER, M E HAGGARD

❮ Previous
Next ❯

Citations

Jun 19, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·S G GokhaleS Gokhale
Jan 24, 1976·Lancet
Nov 1, 1996·Pediatric Pathology & Laboratory Medicine : Journal of the Society for Pediatric Pathology, Affiliated with the International Paediatric Pathology Association·A K HaqueT Downs
Jan 29, 2019·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Sanjay Gokhale, Sankalp Gokhale

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.